← All organizations

Catabasis

For profitWebsite ↗

Also known as: Catabasis Pharmaceuticals | Chief Medical Officer, Catabasis

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 8, 2020

Defunct as of Dec 31, 2025

Timeline

2000s

Jun 1, 2008
Catabasis— Founded

2020s

Dec 31, 2025
Catabasis— Defunct

Drugs by trial phase (9 distinct, 13 trials)

Phase 3 (1 own, 0 via acquisition)

edasalonexent

Phase 2 (3 own, 0 via acquisition)

Phase 1 (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (18)

NCT04543370Study chairPhase 1Aug 8, 2020
NCT04543370Lead sponsorPhase 1Aug 8, 2020
NCT03917719Study chairPhase 3Mar 14, 2019
NCT03917719Lead sponsorPhase 3Mar 14, 2019
NCT03703882Lead sponsorPhase 3Oct 2, 2018
NCT03703882Study chairPhase 3Oct 2, 2018
NCT02439216Lead sponsorPhase 1/Phase 2Apr 1, 2016
NCT02608697Lead sponsorPhase 2Oct 1, 2015
NCT02374047Lead sponsorPhase 1Jan 1, 2015
NCT02098278Lead sponsorPhase 2Mar 1, 2014
NCT01968720Lead sponsorPhase 2Oct 1, 2013
NCT01912560Lead sponsorPhase 2Jul 1, 2013
NCT01725594Lead sponsorPhase 1Nov 1, 2012
NCT01670773Lead sponsorPhase 1Aug 1, 2012
NCT01670773Study directorPhase 1Aug 1, 2012

Details

Founded: Cambridge, MA, US Jun 1, 2008
Last known activity: Aug 8, 2020